title: Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.
abstract: Qsymia™ (Vivus Inc, Mountain View, CA, USA), a combination of phentermine and delayed-release topiramate, has been available in the US since September 2012 for the treatment of obesity. Phentermine is an anorexigenic agent, which is approved for the short-term treatment of obesity, while topiramate is approved for nonweight loss indications - seizure disorders and migraine prophylaxis. The amount of weight loss achieved with combination therapy is of a greater magnitude than what could be achieved with either agent alone. Adverse events that occur with the combination therapy are in line with the known side effect profiles of the constituent drugs; teratogenicity, a slight increase in heart rate, psychiatric and cognitive adverse effects, and metabolic acidosis are concerns.
authors: Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA.
authors: Jin Hee
authors: JH
authors: Shin
authors: Kishore M
authors: KM
authors: Gadde
keywords: Qsymia; antiobesity drugs; combination drug; obesity; phentermine; topiramate; weight loss
references: Diabetes Obes Metab. 2007 May;9(3):360-8
references: 17391164
references: Epilepsy Res. 2011 Aug;95(3):189-99
references: 21684121
references: J Clin Invest. 2006 Jul;116(7):1784-92
references: 16823476
references: Curr Drug Saf. 2009 Jan;4(1):2-4
references: 19256104
references: Epilepsia. 2000;41(S1):35-9
references: 10768298
references: BMJ. 2010 Feb 09;340:c824
references: 20144986
references: Obes Res. 2003 Jun;11(6):722-33
references: 12805393
references: Am J Psychiatry. 2003 Feb;160(2):255-61
references: 12562571
references: Obes Rev. 2000 Oct;1(2):113-9
references: 12119984
references: Arch Intern Med. 2012 Nov 12;172(20):1557-64
references: 23147455
references: Brain Res. 2009 Mar 25;1262:16-24
references: 19401161
references: Neuropsychopharmacology. 2003 Jul;28(7):1292-9
references: 12700690
references: J Intern Med. 2008 Apr;263(4):336-52
references: 18312311
references: Curr Pharm Des. 2008;14(7):655-60
references: 18336311
references: JAMA. 2004 Feb 4;291(5):605-14
references: 14762040
references: Obes Res. 2000 Dec;8(9):656-63
references: 11225714
references: Lancet. 2011 Apr 16;377(9774):1341-52
references: 21481449
references: Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E617-24
references: 15536205
references: Acta Ophthalmol (Copenh). 1984 Oct;62(5):739-45
references: 6391074
references: Prim Care. 2009 Jun;36(2):407-15
references: 19501251
references: JAMA. 1996 Dec 18;276(23):1907-15
references: 8968018
references: Int J Obes Relat Metab Disord. 2004 Nov;28(11):1399-410
references: 15486569
references: Am J Hypertens. 1999 Feb;12(2 Pt 2):50S-55S
references: 10090295
references: Obes Res. 2004 Oct;12(10):1658-69
references: 15536230
references: Synapse. 2005 May;56(2):94-9
references: 15729739
references: Clin Pharmacokinet. 2004;43(12):763-80
references: 15355124
references: Sleep. 2012 Nov 01;35(11):1529-39
references: 23115402
references: Int J Obes. 1989;13 Suppl 2:39-46
references: 2613427
references: Obes Res. 2003 Apr;11(4):556-62
references: 12690085
references: Am J Cardiol. 2005 Jul 15;96(2):243-51
references: 16018851
references: Am J Clin Nutr. 2012 Feb;95(2):297-308
references: 22158731
references: Lancet. 2005 Oct 1;366(9492):1197-209
references: 16198769
references: Obesity (Silver Spring). 2012 Feb;20(2):330-42
references: 22051941
references: Circulation. 2006 Aug 29;114(9):974-84
references: 16940206
references: Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):353-8
references: 19625958
references: Diabetes Care. 2007 Jun;30(6):1480-6
references: 17363756
references: Neurology. 2008 Jul 22;71(4):272-6
references: 18645165
references: Ann Intern Med. 2011 Oct 4;155(7):434-47
references: 21969342
references: Int J Obes. 1989;13(2):123-36
references: 2663745
references: Pharmacotherapy. 2006 Mar;26(3):375-87
references: 16503717
references: Arch Intern Med. 2000 Apr 10;160(7):898-904
references: 10761953
references: Nutrition. 2000 Oct;16(10):961-6
references: 11054602
references: Int J Obes (Lond). 2007 Jul;31(7):1140-7
references: 17264849
references: Expert Opin Pharmacother. 2009 Apr;10(6):921-5
references: 19351275
references: Eur J Clin Pharmacol. 2007 Sep;63(9):891-2; author reply 893
references: 17632711
references: Int J Obes (Lond). 2007 Jan;31(1):138-46
references: 16703004
references: Am J Ther. 2009 Jul-Aug;16(4):354-64
references: 19092640
references: J Behav Med. 1981 Jun;4(2):159-74
references: 7321034
references: Ann Intern Med. 1993 Oct 1;119(7 Pt 2):764-70
references: 8363212
references: Eur J Clin Pharmacol. 2007 Feb;63(2):123-34
references: 17200837
references: Int J Obes Relat Metab Disord. 2002 Mar;26(3):344-53
references: 11896489